Innovation Pharmaceuticals to Present Brilacidin for Inflammatory Bowel...
BEVERLY Mass. Sept. 05 2018 GLOBE NEWSWIRE Innovation Pharmaceuticals OTCQBIPIX the Company a clinical stage biopharmaceutical company announced today that the Company has been invited to present on...
View ArticleTxCell SA TXCL Pharmaceuticals Healthcare Deals and Alliances Profile Report...
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells. The company provides pipeline products such as...
View ArticleActive Biotech regains global rights to development and commercialization of...
PRESS RELEASE Â Lund Sweden September 5 2018 Active Biotech NASDAQ OMX NORDIC ACTI announced today that it regains the global development and commercialization rights to laquinimod from Teva...
View ArticlePfizer Receives Breakthrough Therapy Designation from FDA for PF06651600 an...
Phase II data accepted for latebreaker news session at 2018 EADV Congress Pfizer Inc. NYSEPFE today announced its investigational oral Janus kinase 3 JAK3 inhibitor PF06651600 received Breakthrough...
View ArticleAbivax SA ABVXFR Remarkable data opens door to $15bn IBD market
goetzpartners securities Limited06Sep2018 1016 GMTBSTFree to access research and investor meetings in a postMiFID2 world.This research report is intended for use only by persons who qualify as...
View ArticleFiber strengthens intestinal barrier and counteracts gastrointestinal problems
Similar to patients with Crohn's disease elderly people with stomach problems have a intestinal barrier that is not functioning optimally.
View ArticleXbrane Biopharma announces product portfolio update with a new full strategic...
Press release20180910 The board of directors of Xbrane Biopharma publ. "Xbrane" or the Company has decided to shift strategic focus in the Company's product pipeline to...
View ArticleCrohns Disease Patients Test Experimental Stem Cell Treatment
CBS News &8211; It&8217;s a painful chronic and for some untreatable condition. More than 700000 Americans suffer from Crohn&8217;s disease an inflammatory bowel disease that causes...
View ArticleFirst and Secondline Biologic Therapies for Crohn's Disease
Several biologic agents are now available for first and second line treatment of Crohn's disease but headtohead trials are lacking. This metaanalysis aimed to compare efficacy of these agents....
View ArticleBristolMyers Squibbs Novel Oral Selective TYK2 Inhibitor Delivered...
Efficacy endpoints including 75 and 90 reduction in the Psoriasis Area and Severity Index PASI 75 PASI 90 were achieved following 12 weeks of treatment with 3 mg daily of BMS986165 Data published in...
View ArticleNutrition Therapy and Crohn's Disease
Source Nemours FoundationRelated MedlinePlus Pages Crohn's Disease
View ArticleFamilies Caring for Individuals with Crohn's Disease and Ulcerative Colitis...
The National Alliance for Caregiving Crohns and Colitis Foundation and ImproveCareNow Partner to Understand the Impact of Inflammatory Bowel Diseases IBD on CaregiversWASHINGTON PRWEB September 13 2018...
View ArticleMorphoSys Announces That its Licensee Janssen has Reported That TremfyaR...
DGAPNews MorphoSys AG Key words Study resultsConference13.09.2018 1016 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany September 13 2018MorphoSys Announces...
View ArticleVasculitis A Link with IBD CMECE
MedPage Today High rates of Crohn's disease and ulcerative colitis seen in patients with giant cell arteritis
View ArticleRedHill Biopharma Ltd RDHL Financial and Strategic SWOT Analysis Review...
RedHill Biopharma Ltd RDHL Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleMedical News Today Is there a cure for Crohn's disease
Crohn's disease is a chronic disease for which there is currently no cure. Researchers are looking into specific bacteria the microbiome and inflammation to try to find a cure. For now the goal of...
View ArticleMedical News Today What to know about Ally's Law
Allys Law or the Restroom Access Act allows people with certain medical conditions to access a restroom if they have an urgent need to use one. These conditions include types of inflammatory bowel...
View ArticlePfizer Presents Positive Phase 2 Data in Alopecia Areata During LateBreaker...
Pfizer Inc. NYSEPFE today announced results from its Phase 2a study of PF06651600 an oral Janus kinase JAK 3 inhibitor and PF06700841 a tyrosine kinase TYK 2JAK1 inhibitor compared to placebo in...
View ArticlePfizer showcases JAK pipeline with midstage results
The pharma will advance its JAK3 inhibitor in alopecia areata while focusing its TYK2JAK1 blocker on psoriasis Crohn&39;s and ulcerative colitis.
View Article